Therapeutic Approach with PCSK9 Inhibitors for Effective Cardiovascular Risk Reduction in Diabetes. ccm [Internet]. 2020 Dec. 3 [cited 2026 Sep. 18];4(6):736-42. Available from: https://fortunejournals.org/ojs/index.php/ccm/article/view/15983